Charles R Bonapace - FDA Investigator Report

Designation: SUPERVISORY INTERDISCIPLINA

Duty Station: Silver Spring MD 20993-0002

Organizations: DHHS FDA CDER OMPT CDER OTS OSIS DNDBE

Overview Statistics

2
Total Inspections
1
Total 483s Issued
0
Warning Letters Issued

Inspection Details

Longest Inspection: 3 days
Shortest Inspection: 3 days
Average Length: 3.0 days

Discover the bigger picture. This is just the tip of the iceberg.

Gain access to comprehensive analysis, detailed reports, AI assistant, and much more.

Schedule a Demo

Charles R Bonapace's Recent Inspections

DateCompanyCityCountryFEI Number483
2019-08-08BioReliance CorporationRockvilleUnited States1122041
2017-09-20AstraZeneca Pharmaceuticals LPGaithersburgUnited States1000198729

Sign Up to get the complete report.

Download 483s and EIRs for Charles R Bonapace

Charles R Bonapace - Co-Inspectors

NameInspectionsLast Inspection
Byungja E Marciante12019
Mark J Seaton12019
Zhou Chen12019
John Dan12017

Charles R Bonapace's Active Locations

  • United States

Charles R Bonapace's Year-wise Inspection Count

  • 2017:1 inspections
  • 2019:1 inspections
Last Updated: 2025-05-14 06:11:22